NCT01254643 arm group 6f0f9b8350eb0b0667b86c9df7390d58 [clinicaltrials_resource:NCT01254643/arm-group/6f0f9b8350eb0b0667b86c9df7390d58]
arm group [clinicaltrials_vocabulary:arm-group]
NCT01254643 arm group 6f0f9b8350eb0b0667b86c9df7390d58 [clinicaltrials_resource:NCT01254643/arm-group/6f0f9b8350eb0b0667b86c9df7390d58]
Bio2RDF identifier
NCT01254643/arm-group/6f0f9b8350eb0b0667b86c9df7390d58
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltri ...... 0f9b8350eb0b0667b86c9df7390d58
description [clinicaltrials_vocabulary:description]
9-valent human papillomavirus ...... t Day 1, Month 2, and Month 6.
identifier
clinicaltrials_resource:NCT01254643/arm-group/6f0f9b8350eb0b0667b86c9df7390d58
title
NCT01254643 arm group 6f0f9b8350eb0b0667b86c9df7390d58
@en
type
label
NCT01254643 arm group 6f0f9b83 ...... f9b8350eb0b0667b86c9df7390d58]
@en